PEBC - Programa de Epigenética y Biología del Cáncer 

Help us to investigate new treatments for children affected by Rett Syndrome: our new Crowdfunding Project in Verkami.

PEBC in "Cancer Research”, "Human Molecular Genetics” and “FEBS J”

The European Research Council will fund a research of Dr. Manel Esteller to improve cancer diagnosis



PEBC update




The Bellvitge Institute for Biomedical Research (IDIBELL) is a research foundation set up on 16th June 2004 as a separate legal entity resulting from a change in name of the former August Pi i Sunyer (FAPS) Foundation, set up in 1988. IDIBELL has scientific cooperation agreements with the following institutions/centres:

- University of Barcelona (UB) and its science park
- Bellvitge University Hospital (HUB)

- Catalan Institute of Oncology (ICO)

- Institute for Imaging Diagnosis (IDI)

- Transfusion Centre and Tissue Bank (CTBT)

It is a great pleasure to announce the launching in 2008 of a new research program devoted to basic research within IDIBELL, The Cancer Epigenetics and Biology Program (PEBC).

.>> more info


Neuropsychopharmacology - Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a >>


Molecular Cell - Liz J, Portela A, Soler M, Gmez A, Ling H, Michlewski G, Calin GA, Guil S, Esteller M. >>


Nature Communications - A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect. Lopez-Serra P, M >>













Generalitat de Catalunya Institut d'Investigacio Biomedica de Bellvitge ICREA Sixth Framework Programme Seventh Framework Programme ERC Ministerio de Sanidad y Consumo Ministerio de Educación y Ciencia

© 2008® | PEBC | Todos los derechos reservados |  WEBMAIL  |  INTRANET  |  FTP